Abstract
Public health agencies have recommended that the public wear face coverings, including face masks, to mitigate COVID-19 transmission. However, the extent to which the public has adopted this recommendation is unknown. An observational study of 3,271 members of the public in May and June 2020 examined face covering use at grocery stores across Wisconsin. We found that only 41.2% used face coverings. Individuals who appeared to be female or older adults had higher odds of using face coverings. Additionally, location-specific variables such as expensiveness of store, county-level population and county-level COVID-19 case prevalence were associated with increased odds of using face coverings. To our knowledge, this is the first direct observational study examining face covering behavior by the public in the U.S., and our findings have implications for public health agencies during the COVID-19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nasia Safdar is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number DP2AI144244. AEK is supported by the National Library of Medicine (NLM) Training Grant to the Computation and Informatics in Biology and Medicine Training Program (NLM5T15LM007359). NLA, AKF, AG, EJGL, MMK, THN, KLR, JHS are supported by the University of Wisconsin-Madison Medical Scientist Training Program (T32GM008692). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval was not required because no personal and identifiable data was collected and all observations took place in the public domain.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Nasia Safdar is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number DP2AI144244. AEK is supported by the National Library of Medicine (NLM) Training Grant to the Computation and Informatics in Biology and Medicine Training Program (NLM5T15LM007359). NLA, AKF, AG, EJGL, MMK, THN, KLR, JHS are supported by the University of Wisconsin-Madison Medical Scientist Training Program (T32GM008692). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Data Availability
All data is available from the corresponding author upon request.
